Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Prospective, Open Label Trial, Uncontrolled to Determine the Efficacy and Safety of Depocyt ® for the Treatment of CNS Relapse in Adult Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma

NCT00388531 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT00388531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00388531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Prospective, Open Label Trial, Uncontrolled to Determine the Efficacy and Safety of Depocyt ® for the Treatment of CNS Relapse in Adult Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma
Lead sponsor
PETHEMA Foundation
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2006
Completion date
June 30, 2011
Enrollment
10 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoblastic leukemia, lymphoma